Your session is about to expire
← Back to Search
Test (device arm) for Contact Dermatitis
Study Summary
This trial is testing a new treatment by comparing it to no treatment at all.
- Contact Dermatitis of Hand
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have plans to be in the sun or be exposed to UV rays that could impact the area being treated during the study.You have a severe form of eczema called exudative atopic dermatitis.You are currently using prescribed corticosteroids or antibiotics, either as creams or pills.You have an infection that is in one specific area of your body.You have received treatment involving light therapy or medications that suppress the immune system in the past 8 weeks.You are currently receiving or planning to receive other treatments for your condition.You have raised, itchy bumps or patches on your skin.You are currently taking or have taken medication in the past that can make your skin sensitive to sunlight.You have mild to moderate hand dermatitis that is stable and not severe.You have a condition that makes your skin very sensitive to sunlight, like Lupus erythematosus, photosensitive eczema, or Albinism.
- Group 1: Test (device arm)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the recruitment process currently open for this trial?
"Affirmative. Clinicaltrials.gov data attests that this clinical trial, which was published on October 7th 2022, is actively seeking 25 new patients at a singular medical centre to participate in the study. The entry was last modified November 5th 2022."
How many people have been accepted into the research program?
"Affirmative, the details found on clinicaltrials.gov demonstrate that this experiment is presently recruiting research subjects. The trial was initially posted on October 7th 2022 and has since been revised once more in November 5th 2022; it seeks 25 participants from a single medical centre."
Is this clinical trial open to individuals older than 25?
"This clinical trial is open to patients aged 21-75. However, those under 18 and over 65 can still participate in 95 or 156 other studies respectively."
Does my profile meet the criteria for participation in this experiment?
"This research project is seeking 25 individuals with dermatitis aged between 21 and 75. Essential prerequisites include: abstaining from topical treatments for contact/irritant dermatitis and oral antibiotics in the 4-week period preceding enrolment, agreeing to use a Syndet non-mediated soap substitute during the trial timeframe, refraining from application of emollients 24 hours prior to assessment days, having mild to moderate SCORAD Index no greater than 50 or Objective SCORAD index not exceeding 40 stable contralateral contact/irritant dermatitis on one hand only which will be treated over 6 weeks while its other side serves as control"
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger